Clinical Trial Update: A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant human growth hormone (JINTOPIN AQ) for short children with Small for Gestational Age; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small For Gestational Age

Drugs mentioned

• JINTOPIN AQ (Recombinant human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Small for Gestational Age Infant | Phase 2 | Status: COMPLETED